Cargando…
Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
Circulating tumor cells (CTCs) have been implicated in tumor progression and prognosis. Techniques detecting CTCs in the peripheral blood of patients with non-small cell lung carcinoma (NSCLC) may help to identify individuals likely to benefit from early systemic treatment. However, the detection of...
Autores principales: | Yu, Xin-Min, Wu, Yi-Chen, Liu, Xiang, Huang, Xian-Cong, Hou, Xiu-Xiu, Wang, Jiu-Li, Cheng, Xiang-Liu, Mao, Wei-Min, Ling, Zhi-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133845/ https://www.ncbi.nlm.nih.gov/pubmed/27827952 http://dx.doi.org/10.3390/ijms17111845 |
Ejemplares similares
-
Circulating cell-free DNA content as blood based biomarker in endometrial cancer
por: Cicchillitti, Lucia, et al.
Publicado: (2017) -
Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
por: Ai, Bo, et al.
Publicado: (2016) -
5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer
por: Zhang, Ji, et al.
Publicado: (2018) -
Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020) -
Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2022)